Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for PF-00610355

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for PF-00610355?

PF-00610355 is an investigational drug.

There have been 4 clinical trials for PF-00610355. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2010.

The most common disease conditions in clinical trials are Lung Diseases, Chronic Disease, and Lung Diseases, Obstructive. The leading clinical trial sponsors are Pfizer and [disabled in preview].

Recent Clinical Trials for PF-00610355
A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy VolunteersPfizerPhase 1
A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.PfizerPhase 2
A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic SubjectsPfizerPhase 2

See all PF-00610355 clinical trials

Clinical Trial Summary for PF-00610355

Top disease conditions for PF-00610355
Top clinical trial sponsors for PF-00610355

See all PF-00610355 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.